Rockwell Medical (RMTI) Tops Q1 EPS by 2c, provides guidance
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.95 million.
GUIDANCE:
Rockwell Medical sees FY2026 revenue of $70-75 million, versus the consensus of $73.769 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
